VTRS · 10-Q · 2026Q3 · Full report
Liquidity and Debt Position
Viatris Inc · 2026-11-05 · Importance 44 · Surprise 24 · In source text
Viatris held $1.79 billion of cash and cash equivalents at September 30, 2026. The company had access to a $3.5 billion revolving facility maturing in September 2029 and a receivables facility of up to $600 million expiring in April 2028; neither facility had outstanding borrowings at quarter-end. The company issued approximately $752.8 million of 4.250% Euro Senior Notes due 2033 and remained compliant with its debt covenants, including a maximum leverage ratio of 3.75 to 1.00.
Key facts
- Viatris had access to $3.5 billion under its 2024 Revolving Facility, which matures in September 2029; up to $1.65 billion could support Commercial Paper Program borrowings. source
- Viatris' Receivables Facility provides for borrowings of up to an aggregate $600 million and expires in April 2028. source
- Viatris received $779.8 million in cash proceeds from the CCPS settlement and sale of Biocon equity shares in 2026. source
- Viatris repaid approximately $1.675 billion of its 3.950% Senior Notes at maturity in 2026. source
- Viatris received approximately $752.8 million of proceeds from issuing 4.250% Euro Senior Notes due 2033. source
- Viatris' net cash from investing activities was $518.1 million for the nine months ended September 30, 2026, compared with $216.5 million used in investing activities in the prior-year period, an increase of $734.6 million. source
- Viatris' net cash used in financing activities was $1.74 billion for the nine months ended September 30, 2026, compared with $1.06 billion in the prior-year period, an increase of $678.7 million. source
- Viatris had $550 million of borrowings and repayments under its 2024 Revolving Facility in 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -4.8% | Viatris repaid approximately $1.675 billion of its 3.950% Senior Notes at maturity in 2026. |
| liability | positive | realized | +4.8% | Viatris repaid approximately $1.675 billion of its 3.950% Senior Notes at maturity in 2026. |
| cash | positive | realized | +2.3% | Viatris received $779.8 million in cash proceeds from the CCPS settlement and sale of Biocon equity shares in 2026. |
| cash | positive | realized | +2.2% | Viatris received approximately $752.8 million of proceeds from issuing 4.250% Euro Senior Notes due 2033. |
| liability | negative | realized | -2.2% | Viatris received approximately $752.8 million of proceeds from issuing 4.250% Euro Senior Notes due 2033. |
| cash | positive | realized | +2.1% | Viatris' net cash from investing activities was $518.1 million for the nine months ended September 30, 2026, compared with $216.5 million… |
| cash | negative | realized | -2.0% | Viatris' net cash used in financing activities was $1.74 billion for the nine months ended September 30, 2026, compared with $1.06 billion… |